Oberland Capital

Venture Capital

Oberland Capital is a dedicated healthcare investment firm founded in 2013 and headquartered in New York, with approximately $3.2 billion in assets under management. The firm provides innovative financing solutions — including royalty monetizations, revenue interest financing, and credit facilities — to biopharmaceutical, diagnostic, and medical device companies. Oberland focuses exclusively on the global healthcare industry, targeting commercial-stage and near-commercial-stage companies.

New York, United States · 2+ investments

Late Stage
Growth
Biotech
Healthcare
Medical Devices
Headquarters
New York, United States
Founded
2013
AUM
$3.2B
Total Investments
2
Last Investment
Dec 2025
Geographic Focus
Global

Investment Thesis

Oberland Capital specializes in healthcare royalty and credit investments, providing non-dilutive capital to healthcare companies in exchange for royalties on future revenues or structured credit returns. The firm targets investments of $20 million to $150 million in commercial or near-commercial-stage healthcare companies, with a focus on biopharmaceuticals, diagnostics, and medical devices.

Oberland Capital is a Venture Capital firm based in New York, United States. It has made 2 investments in Biotech and Healthcare.

Investment History

Sign up to view investment history

Create a free account — 10 credits a month to unlock deal history, amounts, and round details.